普洛药业参与行业对话，共探行业高质量发展新机遇！

市场资讯03-10

（来源：看横店）3月5日至6日，第三届多肽药物产业创新峰会（Peptides 2026）在苏州举行。作为全球领先的一站式CDMO服务企业，普洛药业股份有限公司携全链条多肽技术平台参加盛会，通过专业展台展示、技术深度交流、圆桌对话研讨等多元形式，与业内专家围绕“多肽药物产业化的CMC攻坚与创新破局”这一核心议题进行深入探讨，共话多肽药物产业发展的新趋势，共探行业高质量发展的新机遇。峰会期间，普洛药业...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2618600918?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-03-10 11:16","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2618600918","market":"sh","top_or_hot":-1,"title":"普洛药业参与行业对话，共探行业高质量发展新机遇！","media":"市场资讯","content":"<div>\n<p>（来源：看横店）3月5日至6日，第三届多肽药物产业创新峰会（Peptides 2026）在苏州举行。作为全球领先的一站式CDMO服务企业，普洛药业股份有限公司携全链条多肽技术平台参加盛会，通过专业展台展示、技术深度交流、圆桌对话研讨等多元形式，与业内专家围绕“多肽药物产业化的CMC攻坚与创新破局”这一核心议题进行深入探讨，共话多肽药物产业发展的新趋势，共探行业高质量发展的新机遇。峰会期间，普洛药业...</p>\n\n<a href=\"https://finance.sina.com.cn/wm/2026-03-10/doc-inhqnmhs6364518.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>普洛药业参与行业对话，共探行业高质量发展新机遇！</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n普洛药业参与行业对话，共探行业高质量发展新机遇！\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-10 11:16 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/wm/2026-03-10/doc-inhqnmhs6364518.shtml><strong>市场资讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>（来源：看横店）3月5日至6日，第三届多肽药物产业创新峰会（Peptides 2026）在苏州举行。作为全球领先的一站式CDMO服务企业，普洛药业股份有限公司携全链条多肽技术平台参加盛会，通过专业展台展示、技术深度交流、圆桌对话研讨等多元形式，与业内专家围绕“多肽药物产业化的CMC攻坚与创新破局”这一核心议题进行深入探讨，共话多肽药物产业发展的新趋势，共探行业高质量发展的新机遇。峰会期间，普洛药业...</p>\n\n<a href=\"https://finance.sina.com.cn/wm/2026-03-10/doc-inhqnmhs6364518.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"https://finance.sina.com.cn/wm/2026-03-10/doc-inhqnmhs6364518.shtml","article_id":"2618600918","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2618600918","pubTimestamp":1773112560,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"作为全球领先的一站式CDMO服务企业，普洛药业股份有限公司携全链条多肽技术平台参加盛会，通过专业展台展示、技术深度交流、圆桌对话研讨等多元形式，与业内专家围绕“多肽药物产业化的CMC攻坚与创新破局”这一核心议题进行深入探讨，共话多肽药物产业发展的新趋势，共探行业高质量发展的新机遇。据介绍，普洛药业CDMO多肽平台致力于为多肽药物开发提供全面、端到端的服务。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"162414":"新机遇","BK0239":"医药制造","BK0188":"融资融券","000739":"普洛药业","BK0060":"抗癌"},"translate_title":"Puluo Pharmaceuticals participated in the industry dialogue to explore new opportunities for high-quality development of the industry!","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"162414":1.5,"000739":1.5},"content_text":"（来源：看横店）3月5日至6日，第三届多肽药物产业创新峰会（Peptides 2026）在苏州举行。作为全球领先的一站式CDMO服务企业，普洛药业股份有限公司携全链条多肽技术平台参加盛会，通过专业展台展示、技术深度交流、圆桌对话研讨等多元形式，与业内专家围绕“多肽药物产业化的CMC攻坚与创新破局”这一核心议题进行深入探讨，共话多肽药物产业发展的新趋势，共探行业高质量发展的新机遇。峰会期间，普洛药业商务技术团队向到访嘉宾详细介绍了公司CDMO多肽技术平台的核心能力与服务优势，并针对不同客户在多肽药物开发过程中的问题和需求，进行经验分享和提供定制化的解决方案。普洛药业CDMO多肽平台首席技术官徐财丁博士受邀参与“多肽药物产业化的CMC攻坚与创新破局”主题圆桌论坛，围绕三大核心议题，分享了其在平台建设与项目实践中的经验和见解。据介绍，普洛药业CDMO多肽平台致力于为多肽药物开发提供全面、端到端的服务。依托固相、液相以及固液相结合的多肽合成技术和基于酶催化的非天然氨基酸合成技术，已构建覆盖线性肽、多环肽、修饰肽及偶联肽等复杂多肽的全链条技术平台，单批次产量可达10kg。凭借在多肽合成领域拥有的丰富经验，企业能为全球客户提供从肽先导化合物到商业化生产的一站式服务。目前已有114个多肽项目在推进（含9个原料药项目），覆盖GLP-1受体激动剂等热门靶点。\n\n\n海量资讯、精准解读，尽在新浪财经APP","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2618600918","isCrawlerRequest":true}